The aim of this study was to investigate the association to MS of all three classical HLA class I genes, HLA-A, HLA-B, HLA-C as well as the HLA class II gene, HLA-DRB1, in a Scandinavian cohort of 1,784 patients and 1,660 controls. This evidence concerns the gene HLA-C and myeloid sarcoma.